Petros Pharmaceuticals Inc (PTPI) — Capital Reinvestment Ratio
Latest as of December 2024:
0.01x
Petros Pharmaceuticals Inc (PTPI) has a Capital Reinvestment Ratio of 0.01x as of December 2024, meaning it reinvests 0% of its operating cash flow ($965.40K) in capital expenditures ($5.45K). See Petros Pharmaceuticals Inc free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.01x
Capex / Operating Cash Flow
Operating Cash Flow
$965.40K
USD
Capital Expenditures
$5.45K
USD
Data as of
Dec 2024
Most recent filing
Petros Pharmaceuticals Inc Capital Reinvestment Ratio (2018–2019)
This chart tracks Petros Pharmaceuticals Inc's Capital Reinvestment Ratio across 2 annual periods.
Annual Capital Reinvestment Ratio for Petros Pharmaceuticals Inc (2018–2019)
Year-by-year Capital Reinvestment Ratio for Petros Pharmaceuticals Inc from 2018 to 2019. For live market cap and broader valuation context, see market value of Petros Pharmaceuticals Inc.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2019 | 0.03x | $2.53 Million | $71.54K | ▼ -87.9% |
| 2018 | 0.23x | $8.02 Million | $1.88 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow